GuideOncology
Autopsy in COVID-19: biosafety and specimen collection
Summarises the precautions and recommended specimens when performing autopsies or post-mortem studies in suspected or confirmed COVID-19.
Updated 3 November 2026
When to use it
Pathology, legal and forensic medicine services dealing with a deceased person with suspected or confirmed COVID-19.
Warning
The 2020 guidance (CDC, UK Royal College of Pathologists) was written at the height of the pandemic; CDC keeps its page archived since 2022. Today standard autopsy-suite precautions reinforced for respiratory pathogens apply; follow your institution's biosafety protocol and local regulations.
Risk and principles
SARS-CoV-2 is a risk group 3 pathogen that may persist in tissues after death. The main risk for staff comes from aerosols generated during dissection. The 2020 guidance advised assessing in each case whether an autopsy was needed and, if performed, doing it in a well-ventilated room (ideally negative pressure) with minimal staff.
Keep reading in the app
- Protective equipment
- Recommended specimens
- Findings and interpretation
Practical tip
The main risk for staff is aerosols generated during the autopsy (oscillating saws, lung handling): minimise them.
2 more practical tips in the app.
Reference
- Hanley B, Lucas SB, Youd E, Swift B, Osborn M. Autopsy in suspected COVID-19 cases. J Clin Pathol. 2020;73(5):239-242.
- Centers for Disease Control and Prevention. Collection and submission of postmortem specimens from deceased persons with confirmed or suspected COVID-19 (archived; updated 2022).
Official source: CDC: postmortem specimens in COVID-19 (archived page)
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
